Oral semaglutide drops , sublingual semaglutide , oral tirzepatide , tirzepatide drops , and even GLP-1 patches represent alternatives that may shift pricing dynamics as competition increases
Updated 2024
The clinical trials and FDA guidelines vary between these medications
It carries minimal risk, improves insulin sensitivity, and may prevent diabetes progression
Authorship All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published: Sandro Gentile, Giuseppina Guarino, Teresa Della Corte, Giamiero Marino, Ersilia Satta, Carmine Romano, Carmelo Alfarone, Clelia lamberti and Felice Strollo
Their argument states that Plaintiffs fail to translate these broad allegations into viable causes of action for fraud or breach of warranty. 12.18.24 FDA warns about compounded GLP-1 drugs The FDA published a notice stating their concerns over people taking unapproved GLP-1 drugs
